Delivery Order SPE2DB25D3110-SPE2DB26FTCGF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,823.97 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units. The contract, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a $8,731.21 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on October 24, 2025, with completion expected by October 27, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement typical of pharmaceutical supply transactions under the DLA's medical procurement framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $8,858.64 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.91 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a direct pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $2,980.71 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on November 3, 2025, with completion targeted for November 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,948.10 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,770.92 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside provisions and is classified as a firm fixed price delivery order, with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a $9,945.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,871.10 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of June 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB26FTCGFDelivery Order
The Defense Logistics Agency awarded a $9,560.12 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, fulfilling the federal government's pharmaceutical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio demonstrates its established capacity to meet diverse pharmaceutical procurement needs across multiple therapeutic domains through open competition with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 11/6/25 |